Journal List > J Korean Rheum Assoc > v.14(4) > 1003599

Oh, Cho, Ryu, Lee, Cho, Choi, Oh, Ahn, Song, and Lee: A Case of Isoniazid Induced Systemic Lupus Erythematosus

Abstract

Many drugs have been known to induce lupus-like syndrome, composing approximately 10% of all SLE cases. Isoniazid-induced lupus erythematosus affects either sex equally and the most common presenting feature is arthralgia or arthritis with anemia. Fever and pleuritis occur in approximately half of the cases, and pericarditis in approximately 30% of cases. We discribe a 28-year-old woman receiving antituberculous medications including isoniazid for one month. She was hospitalized with fever, arthralgia and newly developed pleural effusion The analysis of pleural fluid and serum revealed an elevated level of antinuclear antibody. We suspected of drug induced lupus and stopped isoniazid medication. After discontinuation of isoniazid and short course of prednisolone treatment, her symptoms and pleural effusion disappeared. This case is to our knowledge, the fist report of isoniazid induced SLE in Korea.

REFERENCES

1). Hoffman BJ. Sensitivity to sulfadiazine resembling acute disseminated lupus erythematosus. Arch Dermatol Syphilis. 1945. 51:190–2.
crossref
2). Lee SL., CHase PH. Drug-induced systemic lupus erythematosus: a critical review. Semin Arthritis Rheum. 1975. 5:83–103.
3). Weinstein A. Drug-induced systemic lupus erythematosus. Prog Clin Immunol. 1980. 4:1–21.
4). Rothfield NF., Bierer WF., Garfield JW. Isoniazid induction of antinuclear antibodies. A prospective study. Ann Intern Med. 1978. 88:650–2.
5). Atzeni F., Marrazza MG., Sarzi-Puttini P., Carrabba M. Drug-induced lupus erythematosus. Reumatismo. 2003. 55:147–54.
crossref
6). Antonov D., Kazandjieva J., Etugov D., Gospodinov D., Tsankov N. Drug-induced lupus erythematosus. Clin Dermatol. 2004. 22:157–66.
crossref
7). Hess E. Drug-related lupus. N Engl J Med. 1988. 318:1460–2.
crossref
8). Yung RL., Richardson BC. Drug-induced lupus. Rheum Dis Clin North Am. 1994. 20:61–86.
crossref
9). Siddiqui MA., Khan IA. Isoniazid-induced lupus erythematosus presenting with cardiac tamponade. Am J Ther. 2002. 9:163–5.
crossref
10). Kang MJ., Lee YH., Lee JS. Etanercept-induced systemic lupus erythematosus in a patient with rheumatoid arthritis. J Korean Med Sci. 2006. 21:946–9.
crossref
11). Mario SP., Robert L., Ignacio G. Systemic lupus erythematosus induced by isoniazid. Ann Rheum Dis. 1992. 51:1085–7.
12). Rider V., Abdou NI. Gender differences in autoimmunity: molecular basis for estrogen effects in systemic lupus erythematosus. Int Immunopharmacol. 2001. 1:1009–24.
crossref
13). Jiang X., Khursigara G., Rubin RL. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science. 1994. 266:810–3.
crossref
14). Fazano CS., Bertin P. The pharmacological management of drug-induced rheumatic disorders. Expert Opin Pharmacother. 2001. 10:1623–31.
crossref

Fig. 1.
Chest CT finding shows peribronchial distributed centrilobular nodules and tree in bud appearance in both upper lobes and lower lobe superior segment.
jkra-14-431f1.tif
Fig. 2.
Chest X-ray showed multiple nodular opacity and fibrosteaky opacity on both upper lung field with cavitary lesion. Large amount of pleural effusion was seen in right side.
jkra-14-431f2.tif
Fig. 3.
Chest X-ray showed improved lesion of both upper lung fields and disappeared previous right side pleural effusion.
jkra-14-431f3.tif
TOOLS
Similar articles